Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|May 28, 1997

MedSim and Sonus eye contrast training

Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more

Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more effectively. The two companies are planning to develop a contrast module that will run on MedSim's UltraSim ultrasound training simulator (SCAN Special Report 4/97).

UltraSim enables users to conduct virtual ultrasound exams by scanning a mannequin and accessing ultrasound data stored on CD-ROM that correspond to the area being examined. Sonus hopes an UltraSim contrast module will help the company train large numbers of physicians in the use of its EchoGen contrast agent for echocardiography. The companies plan to conduct a feasibility study on the module at a major U.S. ultrasound teaching institution.

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.